ClosedResearch announcementOpportunity RFA-FD-10-001

Minor Use Minor Species Development of Drugs; Research Project Grant (R01)

Food and Drug Administration · Department of Health and Human Services

At a glance

Minor Use Minor Species Development of Drugs; Research Project Grant (R01) is a closed federal grant opportunity from the Food and Drug Administration (Department of Health and Human Services). The application deadline was May 14, 2010. Individual awards are listed as $50K – $100K, with about 10 awards expected and $750K in total estimated funding. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments, independent school districts and 10 more. Cost sharing is not required. It is funded under Assistance Listing 93.103 (Food and Drug Administration Research).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

Apr 16, 2010Posted
May 14, 2010Application deadline

Posted: Apr 16, 2010
Close date: May 14, 2010
Award floor: $50,000
Award ceiling: $100,000
Est. total funding: $750,000
Expected awards: 10
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Who can apply

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public colleges & universities
Federally recognized tribal governments
Public & Indian housing authorities
Native American tribal organizations
501(c)(3) nonprofits
Nonprofits without 501(c)(3) status
Private colleges & universities
For-profit organizations (not small businesses)
Small businesses
Others (see notice)

Additional information on eligibility (from the notice)

Hispanic-serving Institutions of Higher Education•Historically Black Colleges and Universities (HBCUs)•Tribally Controlled Colleges and Universities (TCCUs) •Alaska Native and Native Hawaiian Serving Institutions Faith-based or Community-based Organization*Federal Government Agencies (that are not part of HHS)

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

This FOA is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions/organizations that propose to develop, or support the development of, new animal drugs for intended minor use in major species or intended use in minor species. Only new animal drug products that have been designated in accordance with the provisions of section 573 of the Federal Food, Drug, and Cosmetic Act (the act) (21 U.S.C. 360ccc-2) and 21 CFR Part 516 are eligible for grants. FDA is authorized to provide grants for designated new animal drugs to assist in defraying the costs of qualified safety and effectiveness testing. This FOA relates to grants to assist in defraying the costs of qualified safety and effectiveness testing when a grant will either result in, or substantially contribute to, approval or conditional approval of a designated MUMS drug. Applicants must include an explanation of how the proposed study will help gain product approval or conditional approval in the applications Background and Significance section. All funded studies are subject to the requirements of the act (21 U.S.C. 331 et seq.), regulations issued under it, and applicable Department of Health and Human Services (HHS) statutes and regulations.

Additional information from the agency ↗

Full announcement & documents

The full announcement has the complete rules — page limits, required attachments, evaluation criteria and any letter-of-intent dates. Files download directly from Grants.gov.

Assistance Listing

What is an ALN?

93.103Food and Drug Administration ResearchProgram →

Reported obligations under ALN 93.103

Historical data · not a prediction

FY18

$173M

FY19

$199M

FY20

$212M

FY21

$219M

FY22

$256M est.

FY23

$247M est.

Source: SAM.gov Assistance Listing 93.103. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Food & Drug Administration
Vieda.Hubbard@fda.hhs.gov
301-827-7162

Quick answers

Who is eligible to apply for “Minor Use Minor Species Development of Drugs; Research Project Grant (R01)”?

The official notice names these applicant types as eligible: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public colleges & universities, Federally recognized tribal governments, Public & Indian housing authorities, Native American tribal organizations, 501(c)(3) nonprofits, Nonprofits without 501(c)(3) status, Private colleges & universities and 3 more. Additional restrictions may apply; review the full notice.

How much funding is available through “Minor Use Minor Species Development of Drugs; Research Project Grant (R01)”?

Per the notice, individual awards are listed as $50k – $100k, total estimated program funding is $750,000 and the agency expects to make about 10 awards.

How do I apply for “Minor Use Minor Species Development of Drugs; Research Project Grant (R01)”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity RFA-FD-10-001), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

OpenResearchALN 93.103